Exhaled Nitric Oxide in Systemic Sclerosis Lung Disease

Table 5

Correlation between conducting airway NO () and pulmonary function testing.

Group	TLC	FEV1	FVC	DLCO
SSc	0.46 (−0.01, 0.76)	0.32 (−0.17, 0.68)	0.05 (−0.43, 0.50)	0.05 (−0.42, 0.51)
SSc-PAH	−0.79 (−0.98, 0.04)	−0.41 (−0.89, 0.50)	−0.33 (−0.87, 0.56)	−0.88 (−0.99, −0.26)
SLE-PAH	0.42 (−0.73, 0.95)	−0.44 (−0.95, 0.72)	−0.10 (−0.90, 0.85)	0.58 (−0.62, 0.97)
SSc-ILD	0.23 (−0.94, 0.98)	0.08 (−0.95, 0.97)	−0.47 (−0.99, 0.90)	0.59 (−0.86, 0.99)
IPAH	−0.25 (−0.88, 0.70)	−0.49 (−0.89, 0.33)	−0.40 (−0.86, 0.42)	0.30 (−0.68, 0.89)

Bold denotes significant correlations.